Tocilizumab inhibits interleukin-6-mediated matrix metalloproteinase-2 and -9 secretions from human amnion cells in preterm premature rupture of membranes

Gynecologic and Obstetric Investigation

Volumn 68, Issue 3, 2009, Pages 145-153

  Mano, Yukio ^a   Shibata, Kiyosumi ^a   Sumigama, Seiji ^a   Hayakawa, Hiromi ^a   Ino, Kazuhiko ^a   Yamamoto, Eiko ^a   Kajiyama, Hiroaki ^a   Nawa, Akihiro ^a   Kikkawa, Fumitaka ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Amnion cells; Intra amniotic inflammation; Preterm premature rupture of membranes; Tocilizumab

Indexed keywords

ATLIZUMAB; GELATINASE A; GELATINASE B; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

AMNION CELL; ARTICLE; CELL INVASION; CESAREAN SECTION; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME RELEASE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; PREMATURE FETUS MEMBRANE RUPTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM;

AMNION; ANTIBODIES, MONOCLONAL; BLOTTING, WESTERN; CELL LINE; EPITHELIAL CELLS; FEMALE; FETAL MEMBRANES, PREMATURE RUPTURE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-1BETA; INTERLEUKIN-6; INTERLEUKIN-8; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; PEPTIDE FRAGMENTS; PREGNANCY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 67651006538     PISSN: 03787346     EISSN: None     Source Type: Journal    
DOI: 10.1159/000229021     Document Type: Article

References (35)

1. Mercer BM: Preterm premature rupture of the membranes. Obstet Gynecol 2003; 101: 178-193.
2. Parry S, Strauss JF: Premature rupture of the fetal membranes. N Engl J Med 1998; 338: 663-668.
3. Vadillo-Ortega F, Hernandez A, Gonzalez- Avila G, Bermejo L, Iwata K, Strauss JF: Increased matrix metalloproteinase activity and reduced tissue inhibitor of metalloproteinase- 1 levels in amniotic fluids from pregnancies complicated by premature rupture of membranes. Am J Obstet Gynecol 1996; 174: 1371-1376.
4. Vadillo-Ortega F, González-Avila G, Furth EE, et al.: 92-kd type IV collagenase (matrix metalloproteinase-9) activity in human amniochorion increases with labor. Am J Pathol 1995; 146: 148-156.
5. Lei H, Vadillo-Ortega F, Paavola LG, Strauss JF: 92-kDa gelatinase (matrix metalloproteinase- 9) is induced in rat amnion immediately prior to parturition. Biol Reprod 1995; 53: 339-344.
6. Bryant-Greenwood GD, Yamamoto SY: Control of peripartal collagenolysis in the human chorion-decidua. Am J Obstet Gynecol 1995; 172: 63-70.
7. Halabourt JT, Uldberg N, Helmig R, Ohlsson K: The concentration of collagen and collagenolytic activity in the amnion and the chorion. Eur J Obstet Gynecol Reprod Biol 1989; 31: 75-82.
8. Romero R, Mazor M, Wu YK, Sirtori M, Oyarzun E, Mitchell MD, Hobbins JC: Infection in the pathogenesis of preterm labor. Sem Perinatol 1988; 12: 262-279.
9. Zaga V, Estranda-Gutierrez G, Beltran- Montoya J, Maida-Claros R, Lopez-Vancell R, Vadillo-Ortega F: Secretion of interleukin- 1 beta and tumor necrosis factor alpha by whole fetal membranes depends on initial interactions of amnion or chorion with lipopolysaccharides or group B streptococci. Biol Reprod 2004; 71: 1296-1302.
10. Asrat T: Intra-amniotic infection in patients with preterm prelabor rupture of membranes: pathophysiology, detection, and management. Clin Perinatol 2001; 28: 735-751.
11. Goldenberg RL, Andrews WW, Hauch JC: Markers of preterm birth. Prenat Neonatal Med 1998; 3: 43-46.
12. Tasci Y, Dilbaz B, Onal BU, Caliskan E, Dilbaz S, Doganci L, Han U: The value of cord blood interleukin-6 levels for predicting chorioamnionitis, funisitis and neonatal infection in term premature rupture of membranes. Eur J Obstet Gynecol Reprod Biol 2006; 128: 34-39.
13. Lundin-Schiler S, Mitchell MD: Prostaglandin production by human chorion leaves cells in response to inflammatory mediators. Placenta 1991; 12: 353-363.
14. Bryant-Greenwood GD: The extracellular matrix of the human fetal membranes: structure and function. Placenta 1998; 19: 1-11.
15. Fortunato SJ, Menon R, Lombardi SJ: Amniochorion gelatinase-gelatinase inhibitor imbalance in vitro: A possible infections pathway to rupture. Obstet Gynecol 2000; 95: 240-244.
16. Nishimoto N, Hashimoto J, Miyasaka N, Yamamoto K, Kawai S, Takeuchi T, Murata N, van der Heijde D, Kishimoto T: Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): evidence of clinical and radiographic benefit from an X ray reader-blinded randomised controlled trial of tocilizumab. Ann Rheum Dis 2007; 66: 1162-1167.
17. Nishimoto N, Kanakura Y, Aozasa K, Johkoh T, Nakamura M, Nakono S: Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman disease. Blood 2005; 106: 2627-2632. (Pubitemid 41510733)
18. Ogawa J, Harigai M, Akashi T, Nagasaka K, Suzuki F, Tominaga S, Miyasaka N: Exacerbation of chronic active Epstein-Barr virus infection in a patient with rheumatoid arthritis receiving humanised anti-interleukin- 6 receptor monoclonal antibody. Ann Rheum Dis 2006; 65: 1667-1669.
19. Shibata K, Kajiyama H, Ino K, Terauchi M, Yamamoto E, Nawa A, Nomura S, Kikkawa F: Twist expression in patients with cervical cancer is associated with poor disease outcome. Ann Oncol 2008; 19: 81-85.
20. Shibata K, Kikkawa F, Nawa A, Suganuma N, Hamaguchi M: Fibronectin secretion from human peritoneal tissue induces M r 92,000 type IV collagenase expression and invasion in ovarian cancer cell lines. Cancer Res 1997; 57: 5416-5420.
21. Fortunato SJ, Menon R, Lombardi SJ, La- Fleur B: Interleukin-10 inhibition of gelatinases in fetal membranes: Therapeutic implications in preterm premature rupture of membranes. Obstet Gynecol 2001; 98: 284-288.
22. Fujimoto T, Parry S, Urbanek M, Sammel M, Macones G, Kuivaniemi H, Romero R, Strauss JF 3rd: A single nucleotide polymorphism in the matrix metalloproteinase-1 (MMP-1) promoter influences amnion cell MMP-1 expression and risk for preterm premature rupture of the fetal membranes. J Biol Chem 2002; 277: 6296-6302.
23. Pfeffer F, Casanueva E, Kamar J, Guerra A, Perichart O, Vadillo-Ortega F: Modulation of 72-kilodalton type IV collagenase (matrix metalloproteinase-2) by ascorbic acid in cultured human amnion-derived cells. Biol Reprod 1998; 59: 326-329.
24. Athayde N, Edwin SS, Romero R, Gomez R, Maymon E, Pacora P, Menon R: A role for matrix metalloproteinase-9 in spontaneous rupture of the fetal membranes. Am J Obstet Gynecol 1998; 179: 1248-1253.
25. Maymon E, Romero R, Pacora P, Gervasi MT, Gomez R, Edwin SS, Yoon BH: Evidence of in vivo differential bioavailability of the active forms of matrix metalloproteinases 9 and 2 in parturition, spontaneous rupture of membranes, and intra-amniotic infection. Am J Obstet Gynecol 2000; 183: 887-894.
26. Park KH, Chaiworapongsa T, Kim YM, Espinoza J, Yoshimatsu J, Edwin S, Gomez R, Yoon BH, Romero R: Matrix metalloproteinase 3 in parturition, premature rupture of the membranes, and microbial invasion of the amniotic cavity. J Perinat Med 2003; 31: 12-22.
27. Ota A, Yonemoto H, Someya A, Itoh S, Kinoshita K, Nagaoka I: Changes in matrix metalloproteinase 2 activities in amniochorions during premature rupture of membranes. J Soc Gynecol Investig 2006; 13: 592-597.
28. Katsura M, Ito A, Hirakawa S, Mori Y: Human recombinant interleukin-1 alpha increases biosynthesis of collagenase and hyaluronic acid in cultured human chorionic cells. FEBS Lett 1989; 244: 315-318.
29. So T, Ito A, Sato T, Mori Y, Hirakawa S: Tumor necrosis factor-alpha stimulates the biosynthesis of matrix metalloproteinases and plasminogen activator in cultured human chorionic cells. Biol Reprod 1992; 46: 772-778.
30. Hillier SL, Witkin SS, Krohn MA, Watts DH, Kiviat NB, Eschenbach DA: The relationship of amniotic fluid cytokines and preterm delivery, amniotic fluid infection, histologic chorioamnionitis, and chorioamnion infection. Obstet Gynecol 1993; 81: 941-948.
31. Romero R, Yoon BH, Kenney JS, Gomez R, Allison AC, Sehgal PB: Amniotic fluid interleukin- 6 determinations are of diagnostic and prognostic value in preterm labor. Am J Reprod Immunol 1993; 30: 167-183.
32. Rizzo G, Capponi A, Rinaldo D, Tedeschi D, Arduini D, Romanini C: Interleukin-6 concentrations in cervical secretions identify microbial invasion of the amniotic cavity in patients with preterm labor and intact membranes. Am J Obstet Gynecol 1996; 175: 812-817.
33. Kishida T, Yamada H, Furuta I, Kobayashi N, Hirayama E, Ebina Y, Sakuragi N, Fujimoto S: Increased levels of interleukin-6 in cervical secretions and assessment of the uterine cervix by transvaginal ultrasonography predict preterm premature rupture of the membranes. Fetal Diagn Ther 2003; 18: 98-104.
34. Hibi M, Murakami M, Saito M, Hirano T, Taga T, Kishimoto T: Molecular cloning and expression of an IL-6 signal transducer, gp130. Cell 1990; 63: 1149-1157.
35. Mihara M, Kasutani K, Okazaki M, Nakamura A, Kawai S, Sugimoto M, Matsumoto Y, Ohsugi Y: Tocilizumab inhibits signal transduction mediated by both mIL-6R and sIL-6R, but not by the receptors of other members of IL-6 cytokine family. Int Immunopharmacol 2005; 5: 1731-1740.